Lusher M - Search Results

1

Current pitfalls in the measurement of the 4977 bp mitochondrial DNA common deletion in human skin.

Krishnan KJ, Lindsey J, Lusher M, Lowes S, Birch-Machin MA. Krishnan KJ, et al. Among authors: lusher m. J Invest Dermatol. 2003 Jun;120(6):981-2. doi: 10.1046/j.1523-1747.2003.12254.x. J Invest Dermatol. 2003. PMID: 12787124 No abstract available.

2

Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours.

Lindsey JC, Lusher ME, Strathdee G, Brown R, Gilbertson RJ, Bailey S, Ellison DW, Clifford SC. Lindsey JC, et al. Int J Cancer. 2006 Jan 15;118(2):346-52. doi: 10.1002/ijc.21353. Int J Cancer. 2006. PMID: 16049974 Free article.

3

Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2.

Anderton JA, Lindsey JC, Lusher ME, Gilbertson RJ, Bailey S, Ellison DW, Clifford SC. Anderton JA, et al. Among authors: lusher me. Neuro Oncol. 2008 Dec;10(6):981-94. doi: 10.1215/15228517-2008-048. Epub 2008 Jul 29. Neuro Oncol. 2008. PMID: 18664619 Free PMC article.

4

Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.

Lindsey JC, Lusher ME, Anderton JA, Bailey S, Gilbertson RJ, Pearson AD, Ellison DW, Clifford SC. Lindsey JC, et al. Carcinogenesis. 2004 May;25(5):661-8. doi: 10.1093/carcin/bgh055. Epub 2003 Dec 19. Carcinogenesis. 2004. PMID: 14688019

5

The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma.

Frank AJ, Hernan R, Hollander A, Lindsey JC, Lusher ME, Fuller CE, Clifford SC, Gilbertson RJ. Frank AJ, et al. Brain Res Mol Brain Res. 2004 Feb 5;121(1-2):137-40. doi: 10.1016/j.molbrainres.2003.11.016. Brain Res Mol Brain Res. 2004. PMID: 14969745

6

Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development.

Lusher ME, Lindsey JC, Latif F, Pearson AD, Ellison DW, Clifford SC. Lusher ME, et al. Cancer Res. 2002 Oct 15;62(20):5906-11. Cancer Res. 2002. PMID: 12384556

7

Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma.

Hamilton DW, Lusher ME, Lindsey JC, Ellison DW, Clifford SC. Hamilton DW, et al. Cancer Lett. 2005 Sep 8;227(1):75-81. doi: 10.1016/j.canlet.2004.11.044. Epub 2004 Dec 25. Cancer Lett. 2005. PMID: 16051033

8

beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.

Ellison DW, Onilude OE, Lindsey JC, Lusher ME, Weston CL, Taylor RE, Pearson AD, Clifford SC; United Kingdom Children's Cancer Study Group Brain Tumour Committee. Ellison DW, et al. J Clin Oncol. 2005 Nov 1;23(31):7951-7. doi: 10.1200/JCO.2005.01.5479. J Clin Oncol. 2005. PMID: 16258095

9

Epigenetic events in medulloblastoma development.

Lindsey JC, Anderton JA, Lusher ME, Clifford SC. Lindsey JC, et al. Among authors: lusher me. Neurosurg Focus. 2005 Nov 15;19(5):E10. doi: 10.3171/foc.2005.19.5.11. Neurosurg Focus. 2005. PMID: 16398460 Review.

10

Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.

Clifford SC, Lusher ME, Lindsey JC, Langdon JA, Gilbertson RJ, Straughton D, Ellison DW. Clifford SC, et al. Among authors: lusher me. Cell Cycle. 2006 Nov;5(22):2666-70. doi: 10.4161/cc.5.22.3446. Epub 2006 Nov 15. Cell Cycle. 2006. PMID: 17172831

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page